Sebastian Müller

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · The Lancet Oncology · 2014 · 1.7K citations

Cetuximab Versus Folfiri, Oncology, Clinical Trials +9

Salinomycin kills cancer stem cells by sequestering iron in lysosomes

Trang Thi, Ahmed Hamaï, Antje Hienzsch et al. · Nature Chemistry · 2017 · 597 citations · Full text

Malignant Disease, Medicine, Stem Cell Toxicology +10

A Novel Small Molecule That Alters Shelterin Integrity and Triggers a DNA-Damage Response at Telomeres

Raphaël Rodriguez, Sebastian Müller, Justin A. Yeoman et al. · Journal of the American Chemical Society · 2008 · 491 citations · Full text

Formation of tight junction: determinants of homophilic interaction between classic claudins

Jörg Piorntek, Lars Winkler, Hartwig Wolburg et al. · The FASEB Journal · 2007 · 380 citations

Proteinlipid Interaction, Molecular Biology, Cytoskeleton +18

PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers

Géraldine Gentric, Yann Kieffer, Virginie Mieulet et al. · Cell Metabolism · 2018 · 290 citations · Full text

Metabolic Remodeling, Human Ovarian Cancers, Redox Biology +16